IP Library Granted Patent US 9,493,753
Granted Patent B2
US 9,493,753 · App. 14/005,076 · Granted Nov 15, 2016

Modified α-glucosidase and applications of same

Inventor: Satoru Ishihara (Kakamigahara, JP)
Assignee: AMANO ENZYME INC.
C12N9/2428C12N9/1051C12N9/2408C12P19/16C12P19/18C12Y302/0102Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,493,753
App. No.
14/005,076
Granted
Nov 15, 2016
Kind
B2
Abstract

The object is to provide an α-glucosidase in which a transglycosylation activity predominates, and use thereof, and the like. A modified α-glucosidase consisting of an amino acid sequence in which one or two or more of the amino acid(s) is selected from a group of specific amino acids.

Claims (31)

1. A modified α-glucosidase which (a) consists of an amino acid sequence which is identical to SEQ ID NO: 2 except for a substitution at a position corresponding to position 343 of SEQ ID NO: 2, or (b) comprises an amino acid sequence which has 95% or more identity with SEQ ID NO: 2 and comprises a substitution corresponding to position 343 of SEQ ID NO: 2,

wherein the amino acid at position 343 is substituted by a cysteine, aspartic acid, methionine, histidine, alanine, phenylalanine, glycine, threonine, glutamic acid, valine, glutamine, asparagine or isoleucine, and

wherein the modified α-glucosidase has at least one of: improved transglycosylation activity compared to the α-glucosidase of SEQ ID NO: 2, and decreased hydrolysis activity compared to the α-glucosidase of SEQ ID NO: 2.

2. The modified α-glucosidase according to claim 1 , wherein said α-glucosidase consists of the amino acid sequence of SEQ ID No: 20.

3. An enzyme agent comprising the modified α-glucosidase according to claim 2 .

4. A pharmaceutical composition, a composition, a cosmetic composition, a food composition or a feed composition, comprising the modified α-glucosidase according to claim 2 .

5. The α-glucosidase according to claim 2 , having a transglycosylation activity to form α-1,4 or α-1,6 glucosidic linkages.

6. The modified α-glucosidase according to claim 1 , wherein said α-glucosidase (a) consists of the amino acid sequence of SEQ ID No: 20, or (b) comprises an amino acid sequence which has 95% or more identity with the sequence of SEQ ID NO: 20.

7. The modified α-glucosidase according to claim 1 , wherein said α-glucosidase (a) consists of the amino acid sequence of SEQ ID NO.: 20 or (b) comprises an amino acid sequence which has 98% or more identity with the sequence of SEQ ID NO.: 20.

8. The modified α-glucosidase of claim 1 , wherein said modified α-glucosidase comprises an amino acid sequence which has 95% or more identity with SEQ ID NO: 2 and comprises a substitution corresponding to position 343 of SEQ ID NO: 2, wherein the amino acid at position 343 is substituted by a cysteine, aspartic acid, methionine, histidine, alanine, phenylalanine, glycine, threonine, glutamic acid, valine, glutamine, asparagine or isoleucine, wherein the modified α-glucosidase has at least one of: improved transglycosylation activity compared to the α-glucosidase of SEQ ID NO: 2, and decreased hydrolysis activity compared to the α-glucosidase of SEQ ID NO: 2, and wherein said modified α-glucosidase further comprises one or more amino acid substitutions at an amino acid selected from the group consisting of:

(i) an amino acid corresponding to the amino acid at position 452 of SEQ ID NO: 2;

(ii) an amino acid corresponding to the amino acid at position 496 of SEQ ID NO: 2;

(iii) an amino acid corresponding to the amino acid at position 410 of SEQ ID NO: 2;

(iv) an amino acid corresponding to the amino acid at position 495 of SEQ ID NO: 2;

(v) an amino acid corresponding to the amino acid at position 498 of SEQ ID NO: 2;

(vi) an amino acid corresponding to the amino acid at position 499 of SEQ ID NO: 2;

(vii) an amino acid corresponding to the amino acid at position 531 of SEQ ID NO: 2;

(viii) an amino acid corresponding to the amino acid at position 533 of SEQ ID NO: 2;

(ix) an amino acid corresponding to the amino acid at position 579 of SEQ ID NO: 2;

(x) an amino acid corresponding to the amino acid at position 585 of SEQ ID NO: 2;

(xi) an amino acid corresponding to the amino acid at position 662 of SEQ ID NO: 2;

(xii) an amino acid corresponding to the amino acid at position 715 of SEQ ID NO: 2; and

(xiii) an amino acid corresponding to the amino acid at position 721 of SEQ ID NO: 2.

9. The modified α-glucosidase of claim 8 , wherein the modified α-glucosidase comprises a substitution at an amino acid corresponding to the amino acid at position 452 of SEQ ID NO: 2, and the amino acid after the substitution is glycine, aspartic acid or glutamic acid.

10. The modified α-glucosidase of claim 8 , wherein the modified α-glucosidase comprises a substitution at an amino acid corresponding to the amino acid at position 496 of SEQ ID NO: 2, and the amino acid after the substitution is valine, asparagine or glutamine.

11. The modified α-glucosidase of claim 8 , wherein the amino acid corresponding to position 343 of SEQ ID NO: 2 is substituted with aspartic acid, and wherein the amino acid corresponding to position 452 of SEQ ID NO: 2 is substituted with alanine or glycine.

12. The modified α-glucosidase of claim 8 , wherein the amino acid corresponding to position 343 of SEQ ID NO: 2 is substituted with aspartic acid or methionine, and wherein the amino acid corresponding to position 496 of SEQ ID NO: 2 is substituted with isoleucine, arginine, cysteine or threonine.

13. The modified α-glucosidase of claim 8 , wherein the modified α-glucosidase comprises a substitution at an amino acid corresponding to the amino acid at position 495 of SEQ ID NO: 2, and the amino acid after the substitution is glycine, proline or valine.

14. The modified α-glucosidase of claim 8 , wherein the modified α-glucosidase comprises a substitution at an amino acid corresponding to the amino acid at position 498 of SEQ ID NO: 2, and the amino acid after the substitution is leucine or serine.

15. A method for producing an oligosaccharide comprising reacting the modified α-glucosidase of claim 1 with an oligosaccharide or polysaccharide having an α-1,4 glucosidic linkage.

16. A method for producing an oligosaccharide comprising reacting the modified α-glucosidase of claim 13 with an oligosaccharide or polysaccharide having an α-1,6 glucosidic linkage.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2013
From: ISHIHARA, SATORU
To: AMANO ENZYME INC.
Reel/Frame 031203/0459 →
Priority Claims (1)
JP 2011-057386 · Mar 16, 2011 · national
Continuity (1)
Related Publication 20140087405A1 · Mar 27, 2014